Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,577
Closed -$2.04M 58
2023
Q3
$2.04M Buy
7,577
+167
+2% +$41.7K 1.55% 26
2023
Q2
$1.65M Sell
7,410
-412
-5% -$95.6K 0.35% 74
2023
Q1
$1.89M Sell
7,822
-314
-4% -$77.1K 0.36% 80
2022
Q4
$2.14M Buy
8,136
+63
+0.8% +$16.9K 0.43% 73
2022
Q3
$1.82M Buy
8,073
+3,902
+94% +$946K 0.39% 81
2022
Q2
$1.01M Sell
4,171
-25,023
-86% -$6.13M 0.22% 93
2022
Q1
$7.06M Buy
29,194
+21,758
+293% +$5M 1.28% 14
2021
Q4
$1.67M Buy
+7,436
New +$1.57M 0.33% 84

Other funds holding AMGN

TCWP's AMGN Position: Q4 2023 in Review

TCWP sold out of Amgen (AMGN) in Q4 2023, closing a stake of 7,577 shares — an estimated $2.04M sold.

TCWP first reported a position in AMGN in Q4 2021 and held it in 8 quarters. The position peaked at $7.06M in Q1 2022. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • TCWP reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • TCWP sold 7,577 Amgen shares in Q4 2023, an estimated $2.04M.
  • TCWP first reported a position in Amgen in Q4 2021 and held it in 8 quarters.
  • TCWP's Amgen position peaked at $7.06M in Q1 2022.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on TCWP's 13F filing for Q4 2023, filed 14 Feb 2024.